Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02590
Species: Homo sapiens
Position : chr17:69108466-69108765
Year: 2012
Title: Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: prostate cancer
PMID:  22665440
MONDO: MONDO:0008315
Tissue: prostate gland
Tissue Ontology ID: UBERON:0002367
Cell Source: LNCaP
CVCL ID: CVCL_0395
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, TF binding assay; Enhancer activity assay; Disease-variant functional analysis
High Throughput Method: ChIP-seq, DNase-seq; GWAS
Low Throughput Method: Luciferase reporter assay, ChIP-RT-qPCR, Sanger sequencing; Allele-specific reporter assay
About Target Gene
Target gene : SOX9
About TF
TF name : FOXA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
Enhancer Associated Network
Overlapping Enhancers (hg19) 2 found
Enhancer ID Position Tissue Cell Disease
E_02597 chr17:69108466-69108765 prostate gland malignant cell NA
E_02598 chr17:69108466-69108765 prostate gland malignant cell NA
Expression of Target Genes for the Enhancer